114 related articles for article (PubMed ID: 16408832)
1. Differential glutamatergic modulation of monoamine release in the limbic lobe by selective anticonvulsant ionotropic and metabotropic glutamate receptor ligands.
Smolders I
Verh K Acad Geneeskd Belg; 2005; 67(5-6):371-98. PubMed ID: 16408832
[TBL] [Abstract][Full Text] [Related]
2. Direct enhancement of hippocampal dopamine or serotonin levels as a pharmacodynamic measure of combined antidepressant-anticonvulsant action.
Smolders I; Clinckers R; Meurs A; De Bundel D; Portelli J; Ebinger G; Michotte Y
Neuropharmacology; 2008 May; 54(6):1017-28. PubMed ID: 18378264
[TBL] [Abstract][Full Text] [Related]
3. In vivo modulatory action of extracellular glutamate on the anticonvulsant effects of hippocampal dopamine and serotonin.
Clinckers R; Gheuens S; Smolders I; Meurs A; Ebinger G; Michotte Y
Epilepsia; 2005 Jun; 46(6):828-36. PubMed ID: 15946324
[TBL] [Abstract][Full Text] [Related]
4. Hippocampal dopamine and serotonin elevations as pharmacodynamic markers for the anticonvulsant efficacy of oxcarbazepine and 10,11-dihydro-10-hydroxycarbamazepine.
Clinckers R; Smolders I; Meurs A; Ebinger G; Michotte Y
Neurosci Lett; 2005 Dec; 390(1):48-53. PubMed ID: 16139430
[TBL] [Abstract][Full Text] [Related]
5. Controversial action of positive modulator of subtype 7 of metabotropic glutamate receptors AMN082 on cortical epileptic afterdischarges in immature rats.
Szczurowska E; Mares P
Eur J Pharmacol; 2009 Nov; 623(1-3):37-40. PubMed ID: 19765577
[TBL] [Abstract][Full Text] [Related]
6. Sigma 1 receptor-mediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y.
Meurs A; Clinckers R; Ebinger G; Michotte Y; Smolders I
Eur J Neurosci; 2007 Dec; 26(11):3079-92. PubMed ID: 18005069
[TBL] [Abstract][Full Text] [Related]
7. The involvement of glutamate in the pathophysiology of depression.
Palucha A; Pilc A
Drug News Perspect; 2005 May; 18(4):262-8. PubMed ID: 16034483
[TBL] [Abstract][Full Text] [Related]
8. Metabotropic glutamate receptors as a strategic target for the treatment of epilepsy.
Alexander GM; Godwin DW
Epilepsy Res; 2006 Sep; 71(1):1-22. PubMed ID: 16787741
[TBL] [Abstract][Full Text] [Related]
9. On the role of metabotropic glutamate receptors in the mechanisms of action of antidepressants.
Pałucha A; Pilc A
Pol J Pharmacol; 2002; 54(6):581-6. PubMed ID: 12866712
[TBL] [Abstract][Full Text] [Related]
10. Comparing sertindole to other new generation antipsychotics on preferential dopamine output in limbic versus striatal projection regions: mechanism of action.
Hertel P
Synapse; 2006 Dec; 60(7):543-52. PubMed ID: 16952163
[TBL] [Abstract][Full Text] [Related]
11. Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs.
Palucha A; Pilc A
Pharmacol Ther; 2007 Jul; 115(1):116-47. PubMed ID: 17582504
[TBL] [Abstract][Full Text] [Related]
12. On the mechanism of antidepressant-like action of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of the effect of cholecystokinin octapeptide on the monoamine level in rat brain limbic structures in the process of satiation].
Sudakov SK; Kadar T; Varsegi M; Telegdi G
Biull Eksp Biol Med; 1984 Mar; 97(3):290-3. PubMed ID: 6322879
[TBL] [Abstract][Full Text] [Related]
14. Effect of a novel neurotensin analog, NT69L, on nicotine-induced alterations in monoamine levels in rat brain.
Liang Y; Boules M; Shaw AM; Williams K; Fredrickson P; Richelson E
Brain Res; 2008 Sep; 1231():6-15. PubMed ID: 18687313
[TBL] [Abstract][Full Text] [Related]
15. mGlu1 and mGlu5 receptor antagonists lack anticonvulsant efficacy in rodent models of difficult-to-treat partial epilepsy.
Löscher W; Dekundy A; Nagel J; Danysz W; Parsons CG; Potschka H
Neuropharmacology; 2006 Jun; 50(8):1006-15. PubMed ID: 16563443
[TBL] [Abstract][Full Text] [Related]
16. Effects of postnatal isolation rearing and antidepressant treatment on the density of serotonergic and noradrenergic axons and depressive behavior in rats.
Kuramochi M; Nakamura S
Neuroscience; 2009 Sep; 163(1):448-55. PubMed ID: 19524023
[TBL] [Abstract][Full Text] [Related]
17. Regulation of editing and expression of glutamate alpha-amino-propionic-acid (AMPA)/kainate receptors by antidepressant drugs.
Barbon A; Popoli M; La Via L; Moraschi S; Vallini I; Tardito D; Tiraboschi E; Musazzi L; Giambelli R; Gennarelli M; Racagni G; Barlati S
Biol Psychiatry; 2006 Apr; 59(8):713-20. PubMed ID: 16460696
[TBL] [Abstract][Full Text] [Related]
18. Stimulation by neurotensin of dopamine and 5-hydroxytryptamine (5-HT) release from rat prefrontal cortex: possible role of NTR1 receptors in neuropsychiatric disorders.
Petkova-Kirova P; Rakovska A; Zaekova G; Ballini C; Corte LD; Radomirov R; Vágvölgyi A
Neurochem Int; 2008 Dec; 53(6-8):355-61. PubMed ID: 18835308
[TBL] [Abstract][Full Text] [Related]
19. Dopaminergic deficit and mood disorders.
Pania L; Gessab GL
Int Clin Psychopharmacol; 2002 Dec; 17 Suppl 4():S1-7; discussion S7. PubMed ID: 12685916
[TBL] [Abstract][Full Text] [Related]
20. Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies.
Di Matteo V; Di Giovanni G; Pierucci M; Esposito E
Prog Brain Res; 2008; 172():7-44. PubMed ID: 18772026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
